Canada Viscosupplementation Market is Segmented By Dosage (Single Injection, Three Injection, Five I...
Market Size in USD Mn
CAGR7.8%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 7.8% |
Market Concentration | High |
Major Players | Johnson & Johnson., F. Hoffmann-La Roche AG, Zimmer Biomet, Sanofi S.A., Anika Therapeutics Inc. and Among Others |
The Canada Viscosupplementation Market is estimated to be valued at USD 162.6 Mn in 2025 and is expected to reach USD 275.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032.
Viscosupplementation is a nonsurgical treatment used to treat osteoarthritis by replacing lubricating fluid and restoring synovial viscosity. This treatment method is gaining popularity due to the rising prevalence of osteoarthritis and growing geriatric population.